The impact of 10-valent pneumococcal conjugate vaccine on the incidence of admissions to hospital with hypoxaemic and non-hypoxaemic pneumonia in Kenyan children. [PDF]
Haeusler IL +5 more
europepmc +1 more source
A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population. [PDF]
Fiévez S +9 more
europepmc +1 more source
Sex-based difference in immune responses and efficacy of the pneumococcal conjugate vaccine. [PDF]
Tchalla EYI +4 more
europepmc +1 more source
Immunogenicity, safety and adverse events of sequential vaccination with a 10-valent pneumococcal conjugate vaccine (PCV10) and PPSV23 compared with PPSV23 alone in systemic lupus erythematosus. [PDF]
Chatterjee R +4 more
europepmc +1 more source
Pneumococcal carriage among children and adults before and after a change from a three-dose 13-valent pneumococcal conjugate vaccine schedule without a booster to a two-dose schedule with a booster in Burkina Faso. [PDF]
Childs L +16 more
europepmc +1 more source
Related searches:
Pneumococcal conjugate vaccines
Immunology Letters, 1991We have prepared conjugates of pneumococcal type 4 polysaccharides (PS4) or oligosaccharides to tetanus toxoid using the carbodiimide method. The use of a spacer, 6-aminohexanoic acid, resulted in higher incorporation of carrier protein. Conjugates contained up to 10% free polysaccharide, but no free protein.
C C, Peeters +6 more
openaire +4 more sources

